| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |